GlassScriptPhysician profile
Saad Tariq
NPI 1497098636
$1,400.76
in general payments reported to CMS, 2019-2025
10 companies · $57.67 in 2025
The $57.67 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $96.20 · 2021: $241 · 2022: $466 · 2023: $77.51 · 2024: $177 · 2025: $57.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $822.45 | 2019-2024 | Rinvoq, Skyrizi |
| Amgen INC. | $172.50 | 2019-2023 | Evenity, Prolia |
| Siemens Medical Solutions USA, INC. | $143.06 | 2024 | |
| Glaxosmithkline, LLC. | $123.77 | 2021-2025 | Benlysta |
| Lilly USA, LLC | $45.55 | 2022 | |
| Janssen Biotech, INC. | $37.53 | 2019-2021 | |
| Pfizer INC. | $35.22 | 2019 | |
| Ucb, INC. | $20.68 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saad Tariq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.